文献速递关节外科

全关节置换术结局指标的最小临床重要差异(MCID)随计算方法不同而显著变化

The Minimal Clinically Important Difference (MCID) for Total Joint Arthroplasty Outcome Measures Varies Substantially by Calculation Method.
PubMed 文献 · J Bone Joint Surg Am · 2025-03-20

研究纳入2021年6月至2023年6月间接受全膝关节置换术(TKA)或全髋关节置换术(THA)且完成术前及术后1年患者报告结局(KOOS JR或HOOS JR)的1,113例患者,采用16种统计学方法计算MCID并应用于研究队列,评估不同方法对术后1年达到MCID患者数量的影响。结果显示MCID值随方法变化很大,分布法所得MCID较小但变异性更大,锚定法所得MCID较大但更一致;不同统计方法导致的MCID阈值差异影响达到MCID的患者数量。

要点

  • 16种统计学方法计算出的KOOS JR与HOOS JR的MCID值差异很大。
  • 分布法所得MCID值较小但变异性更大,锚定法所得MCID值较大但更一致。
  • MCID阈值的变化影响术后1年达到MCID的患者数量。

核心结论

  • 不同统计方法导致MCID阈值大幅变化,并影响达到MCID的患者数量。
  • 本研究显示MCID存在模糊性,对其用于评估全关节置换术手术获益的效用提出一定疑问。

研究设计与样本

  • 对2021年6月至2023年6月间接受TKA或THA并完成术前及术后1年KOOS JR或HOOS JR的患者进行回顾性分析,共1,113例。
  • 采用16种统计学上合适的方法确定HOOS JR和KOOS JR的MCID值,并将所得MCID值应用于研究组以评估方法差异如何改变术后1年达到MCID的患者数量。
  • 证据等级:预后Level III。

主要发现

  • 研究队列包括570例接受TKA和543例接受THA的患者。
  • 总体队列62.2%为女性,平均年龄69.3 ± 8.3岁,92.3%为白人,2.9%为非裔美国人,4.8%为其他种族(即亚洲人、多种族或「其他」)。
  • KOOS JR的MCID均值为11.5 ± 9.2(范围0.5至36.6),HOOS JR的MCID均值为12.2 ± 8.9(范围0.6至34.3)。
  • 分布法所得MCID值较小但变异性更大,而锚定法所得MCID值较大但更一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the United States health-care system transitions to a value-based model, the minimal clinically important difference (MCID) has become an important metric for assessing perceived benefit in clinical settings. However, there is substantial ambiguity surrounding the MCID value because the calculation method used can lead to substantial changes in the clinical interpretation of surgical success. METHODS: A total of 1,113 patients who underwent either total knee arthroplasty (TKA) or total hip arthroplasty (THA) between June 2021 and June 2023 and completed their patient-reported outcomes (the KOOS JR [Knee injury and Osteoarthritis Outcome Score for Joint Replacement] or HOOS JR [Hip disability and Osteoarthritis Outcome Score for Joint Replacement]) preoperatively and at 1 year postoperatively were reviewed for this study. The MCID values for the HOOS JR and KOOS JR were determined using 16 statistically appropriate methods, and the resulting MCID values were applied to the study group to assess how differences in methods changed the number of patients who met the MCID at 1 year postoperatively. RESULTS: The study cohort consisted of 570 patients who underwent TKA and 543 who underwent THA. The overall cohort was 62.2% female, had a mean age of 69.3 ± 8.3 years, and was 92.3% Caucasian, 2.9% African American, and 4.8% other race (i.e., Asian, multiracial, or "other"). The MCID values varied substantially among the methods evaluated. The mean MCID was 11.5 ± 9.2 (range, 0.5 to 36.6) for the KOOS JR and 12.2 ± 8.9 (range, 0.6 to 34.3) for the HOOS JR. Distribution-based methods led to smaller but more variable MCID values, whereas anchor-based methods were noted to have larger but more consistent MCID values. CONCLUSIONS: Different statistical approaches resulted in substantial variation in the MCID threshold value, which affected the number of patients who reached the MCID. This study demonstrates the ambiguity of the MCID and casts some doubt regarding its utility for assessing the surgical benefit of total joint arthroplasty. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Solomito MJ, Carangelo R, Makanji H, et al. The Minimal Clinically Important Difference (MCID) for Total Joint Arthroplasty Outcome Measures Varies Substantially by Calculation Method. J Bone Joint Surg Am. 2025. PMID: 40112037. doi:10.2106/JBJS.24.00916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。